OTSUKA CORPORATION (4768.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

20.2x

EV/EBITDA

10.7x

Market Cap

JPY 1.37T

MomentumView details →

1D Return

+0.61%

YTD Return

+13.06%

RSI (14)

64.4

ValuationView details →

P/E (Fwd)

20.2x

EV/EBITDA

10.7x

Market Cap

JPY 1.37T

RSI (14)

64.4

MomentumView details →

1D Return

+0.61%

YTD Return

+13.06%

ProfitabilityView details →

Gross Margin

18.65%

Net Margin

4.92%

EBITDA Margin

7.34%

ROE (TTM)

16.72%

ROA (TTM)

8.87%

Asset Turnover

1.83x

GrowthView details →

Revenue YoY

+16.90%

EPS YoY

+18.13%

FCF YoY

+695.64%

Revenue CAGR 3Y

+15.39%

EPS CAGR 3Y

−7.04%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

1.81x

Quick Ratio

1.70x

Div Yield

1.25%

Div Rate

JPY 90.00

Div Growth 1Y

+12.50%

Financials snapshotView financials →

Revenue (TTM)

1.35T

Net Income (TTM)

66.50B

Op. CF (TTM)

115.48B

Next earningsNov 4, 2026 →

Latest newsMore news →

Infomart announced strengthening its collaboration with Otsuka Corporation to promote DX in the manufacturing and wholesale industries, adding its TANOMU ordering system and BP Storage AI-OCR services to Otsuka's 'Tayoreru' business support service.16d ago

Otsuka Holdings presented new Phase 3 trial data for its IgA nephropathy drug sibeprenlimab at GlomCon Hawaii 2026, showing improved eGFR and stabilization of kidney function over two years compared to placebo.32d ago

Similar companies

Dai Nippon Printing Co.,Ltd.7912.T TOHO CO.,LTD9602.T TOPPAN Holdings Inc.7911.T BayCurrent,Inc.6532.T M3,Inc.2413.T Rakuten Group,Inc.4755.T Find similar companies →

Latest newsMore news →

Infomart announced strengthening its collaboration with Otsuka Corporation to promote DX in the manufacturing and wholesale industries, adding its TANOMU ordering system and BP Storage AI-OCR services to Otsuka's 'Tayoreru' business support service.16d ago Otsuka Holdings presented new Phase 3 trial data for its IgA nephropathy drug sibeprenlimab at GlomCon Hawaii 2026, showing improved eGFR and stabilization of kidney function over two years compared to placebo.32d ago